Detalhe da pesquisa
1.
More than one million barriers fragment Europe's rivers.
Nature
; 588(7838): 436-441, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33328667
2.
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
J Pathol
; 253(2): 234-245, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140857
3.
RNA splicing alteration in the response to platinum chemotherapy in ovarian cancer: A possible biomarker and therapeutic target.
Med Res Rev
; 41(1): 586-615, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33058230
4.
A novel 3'-tRNAGlu-derived fragment acts as a tumor suppressor in breast cancer by targeting nucleolin.
FASEB J
; 33(12): 13228-13240, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31560576
5.
Beware small dams, they can do damage, too.
Nature
; 570(7760): 164, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31186570
6.
p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability.
Proc Natl Acad Sci U S A
; 112(45): 13916-21, 2015 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26512117
7.
STAT3 in Breast Cancer Onset and Progression: A Matter of Time and Context.
Int J Mol Sci
; 19(9)2018 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30231553
8.
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis.
Proc Natl Acad Sci U S A
; 110(24): 9845-50, 2013 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23697367
9.
Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development.
Cancer Cell
; 11(3): 275-89, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17349584
10.
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma.
Signal Transduct Target Ther
; 9(1): 31, 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38342897
11.
Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice.
NPJ Breast Cancer
; 10(1): 5, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184660
12.
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer.
EMBO Mol Med
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658801
13.
p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.
Cancer Cell
; 7(1): 51-63, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15652749
14.
Impacts of existing and planned hydropower dams on river fragmentation in the Balkan Region.
Sci Total Environ
; 871: 161940, 2023 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736393
15.
Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth.
Nat Commun
; 14(1): 6777, 2023 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880212
16.
HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel.
Cell Death Dis
; 13(5): 429, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35504904
17.
CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review.
Front Oncol
; 12: 891580, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35712501
18.
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer.
Cancers (Basel)
; 14(16)2022 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36011047
19.
The many facets of miR-223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response.
Wiley Interdiscip Rev RNA
; 12(6): e1659, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951281
20.
Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives.
Cancers (Basel)
; 13(12)2021 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34204543